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Introduction
Peripheral iridotomy is the treatment of choice for
angle closure glaucoma, which is one of the leading causes
of blindness. Overall glaucoma is the second leading cause
of blindness worldwide.1,2 The relative prevalence of its
different types varies geographically with open angle
glaucoma being the predominant form in Caucasians and
angle closure glaucoma in Asians.1,2 Angle-closure
glaucoma is characterized by narrowing or closure of the
anterior chamber angle. Over the last decade laser surgery
has superseded incisional surgery as the preferred method
for creating an opening in the irides for the treatment of
angle-close glaucoma caused by the pupillary block.
The Nd-YAG laser can be used at once in almost all
the situations but is best with lighter coloured irides.  Nd-
YAG laser iridotomy alone is associated with high risk of
failure and complications in dark irides.3,4 The combined
Argon and Nd: YAG technique is excellent for dark eyes,
permitting utilizing advantages of both laser types and
avoiding their disadvantages.5 It is possibly the ideal
technique to use in the Asian Irides.5,6A study conducted in
Singapore showed that  2.65 times less energy was required
with sequential Argon, Nd-YAG laser iridotomy as
compared to using argon laser alone.6 A similar study in
Israel concluded that total energy required using combined
Argon and Nd: YAG technique was lower than using either
laser alone,7 along with good safety and efficacy. Other
studies have shown that argon laser pretreatment
significantly reduces incidence of haemorrhage.8,9
To the best of our knowledge, there is no work
documented from Pakistan in this regards. Hence we
embarked with this study aimed to assess the efficacy and
early and late complications of Argon-YAG combined laser
iridotomy in the outpatient department of a tertiary care
hospital in Karachi, Pakistan.   
Patients and Methods
A prospective observational study was conducted at
the outpatient department of Ophthalmology Aga Khan
University Hospital Karachi, Pakistan. A detailed history of
the patients was taken. Visual acuity recordings, slit lamp
examination, applanation tonometry, gonioscopy and
examination of the fundus were done on all the patients.
Patients with gonioscopic evidence of narrow angles
underwent the Dark-room Prone-position provocative test.
Patient's pre test intra ocular pressure (IOP) was measured
using applanation tonometer. They were then asked to lie
prone in the dark room for an hour. The patient was
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Abstract
Objective: To assess the the efficacy and early and late complications of Argon-YAG combined laser iridotomy
in the outpatient department of a tertiary care hospital.    
Methods:  This was a prospective observational study conducted at Aga Khan University Hospital Karachi,
Pakistan. After detailed history taking and clinical examination, patients who had goniscopically evident closed
angles and a positive provocative test were selected for laser iridotomy. They underwent iridotomy using Argon
laser followed by YAG laser. The main outcome measures were patency of iridotomy at 6 months, angle grading
at 6 months and early and late complications. 
Results: Overall 40 eyes of 30 patients underwent iridotomy. Of these 18 (60%) were female. At presentation,
26, 10, 2 and 2 eyes had primary angle closure glaucoma (PACG), prodromal stage of PACG, chronic angle
closure glaucoma, and seculusio papillae with iris bombe secondary to uveitis, respectively.
All the 40 iridotomies were patent at 6 months follow up. Majority of the eyes with primary acute angle closure
glaucoma, and prodromal angle closure glaucoma had their angles opened from Grade 0 and Grade I to Grade
III. At 6 months, 30(75%) eyes had a good control of intraocular pressure (IOP). Intraoperative complication,
encountered were microhyphaema in 14 eyes and 2 developed corneal burns. Postoperative complications were
transient rise of IOP in 18 eyes and post-laser iritis in 32 eyes, but they responded to recommended treatment. 
Conclusions: Iridotomy with Argon laser followed by Nd-YAG laser was associated with good clinical outcome
and fewer complications in eyes with PACG (JPMA 60:220; 2010).
accompanied by an attendant all this time to make sure the
patient stayed awake during the test. At the end of the test
the IOP was recorded again. A rise of 8 mm Hg from the
baseline was taken as a positive provocative test. After
detailed history taking and clinical examination, patients
who had goniscopically evident closed angles and a positive
provocative test (Dark-room Prone-position Test) were
selected for laser iridotomy. They were briefed about the
procedure and written consent was taken. The study
extended for over 15 months and there were 30 patients
(40eyes) treated as part of the study. 
All the laser iridotomies were performed as an
outpatient procedure. A combination of Argon and YAG for
laser iridotomy was used in all the patients. Nd: YAG laser
Abraham iridotomy lens was used in our study as a focusing
lens before application of laser to the iris using
methylcellulose as a coupling solution. We used power of
1000mw for Argon laser with spot size of 50 microns
requiring 50-80 Number of shots. In Nd: YAG laser we used
power of 4-6 mJ requiring 3-5 shots. The argon laser was
used to thin the iris so that approximately 20% of the tissue
remains.  When this was accomplished, the patient was
moved to the Nd: YAG laser.  The Nd: Yag laser beam was
then focused into the depth of the creator already made with
the help of argon laser and 2-3 shots were needed to
complete the iridotomy. The iridotomy was considered
complete when the anterior lens capsule could be seen
through the opening made by the iridotomy.
Post laser management included, IOP monitoring
which was checked 1 and 2 hours post laser. All the patients
were discharged on topical steroid (prednisolone acetate)
four times a day and a topical beta blocker twice a day. This
combination of steroid and anti glaucoma therapy was
continued for five days, after which they were stopped. 
After the discharge, the patients were followed at 1
day, 1 week, 4 weeks, 3 month and 6 month intervals. If at
6 months post laser their iridotomies were patent, the intra
ocular pressure normal and provocative test negative, the
treatment was considered successful.
At each visit in addition to the routine
ophthalmologic examination including measurement of
visual acuity and applanation IOP, the status of the
overlying corneal endothelium, anterior chamber reaction
and iridotomy patency were evaluated. In addition,
goniscopy was done to confirm that the pupillary block had
been relieved and to determine the extent of PAS. All
patients underwent provocative testing on the 7th day
following laser, after discontinuation of hypotensive
medication. 
The main outcome measures were (1). Patency of
iridotomy at 6 months (2), angle grading at 6 months and (3)
early and late complications. 
The data were entered and analyzed using SPSS
version 15.0(SPSS Inc., Chicago, IL). Percentages,
frequencies were calculated and tables were made for rate of
complications and outcome variables. 
Results
In all, 40 eyes of 30 patients were subjected to
iridotomy. Of these 18 (60%) were females and 12 (40%)
were males (Table-1). At presentation, 26, 10, 2 and 2 eyes had
primary angle closure glaucoma (PACG), prodromal stage of
PACG, chronic angle closure glaucoma, and seculusio papillae
with iris bombe secondary to uveitis, respectively. 
Headache was the most common presenting symptom
present in 24 patients (80%), followed by blurred vision 17
(56.6%), coloured haloes 15 (50%), painful red eyes 15(50%)
and ocular pain 13 (43.3%). Almost 100% of the patients had
shallow anterior chamber. Ciliary congestion was noted in 17
eyes (42.5%) and corneal oedema in 18 eyes (45%). The pre
treatment IOP in all the patients with corneal oedema was
more than 45 mmHg. Pupil was normally reacting in 10 eyes
(25%) and mid dilated with very sluggish reaction was
present in 30 eyes (75%). Iris atrophy was seen in 2 eyes
(5%). On gonioscopy 22 (55%) eyes had totally closed angle
i.e. grade zero according to Shaffer's classification at
presentation (Table-2).
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Table-1: Demography of patients undergoing laser peripheral
iridotomy at a tertiary care hospital in Pakistan (n=30).
Gender Number (Percentage)
Male 12 (40%)
Female 18 (60%)
Age
40 - 50 years 15 (50%)
51-60 years 10 (33.33%)
61 - 70 years 5 (16.66%)
Family History
Positive 5 (16.66%)
Refractive Error
Emmetropic 8 (20%)
Hypermetropic 32 (80%)
Table-2: Angle grading at presentation and on
final follow-up at 6th month post laser peripheral iridotomy
at a tertiary care hospital in Pakistan (n=40).
Number Angle grading  at Angle grading  at
presentation 6th month follow-
up
22 Grade 0 Grade 3
18 Grade 1 Grade 3
Peripheral Anterior Synechiae
4 eyes with PAS < 1/2 of angle Grade 1 Grade 2
There was no closure of iridotomy at 6 months
follow up. All 40 iridotomies were patent as judged by
retroillumination. Regarding post laser appearance of the
angle width, majority of the eyes with primary acute angle
closure glaucoma, and prodromal angle closure glaucoma
had their angles opened from Grade 0 and Grade I to Grade
III and deepening of the anterior chamber (Table-2). Two
eyes with PAS involving more than half of the angle did not
show any improvement.
Majority of the eyes 30(75%) had a good control of
the IOP at 6 months follow up period. Two patients (2eyes)
who had PAS involving more than half of the angle did not
show reduction in IOP and were eventually treated with
trabeculectomy. Three patients out of 4 who had PAS
involving less than half of the angle, showed slight
reduction of IOP, with pressures of 27, 26, 28 mmHg
respectively. They were prescribed topical beta blockers
twice a day, which brought their pressures to 19-20 mm Hg. 
The patients were followed up after one month, three
months and six months. No serious complication occurred.
Some minor and transient complications that occurred are
given in Table-3.
One patient developed corneal endothelial whitening
during argon photocoagulation of the iris due to energy
absorption by the endothelium. The lesion was small and
did not affect corneal clarity or function. One patient
developed posterior synechae at 12' clock meridian,
detected in the 3rd day follow up. One patient developed
anterior subcapsular lens opacity under the iridotomy site
which was non progressive upto 6 months follow up.
Discussion
The Nd-YAG laser alone is most effective in light
coloured irides.5,10 Nd-YAG laser iridotomy alone is
associated with high risk of failure and complications in
dark irides.3,4 It is complicated in up to 40% cases with iris
haemorrhage.11-14 The haemorrhage may be severe enough
to postpone the procedure or repeat the iridotomy at an
alternative site.5
The combined Argon and Nd: YAG technique is
more appropriate for dark eyes, permitting utilizing
advantages of both laser types and avoiding their
disadvantages.  It is possibly the ideal technique to use in
Asian Irides.5,6 The argon laser is used to thin the iris so that
approximately 20% of the tissue remains.  When this is
accomplished, The Nd: Yag laser beam is then focused into
the depth of the creator already made with the help of argon
laser to complete the iridotomy requiring only a third of the
corresponding power reported for pure YAG laser
iridotomy.15
In our study all the the 40 iridotomies were patent at
6 months follow-up. Regarding post laser appearance of the
angle width, majority of the eyes with primary acute angle
closure glaucoma, and prodromal angle closure glaucoma
had their angles opened from Grade 0 and Grade I to Grade
III and deepening of the anterior chamber. Two eyes with
PAS involving more than half of the angle did not show any
improvement.
In our study over one third (35%) of the patients
developed a transient micro hyphaema at the time of
iridotomy and 45% patients developed transient rise of IOP
at 2-6 hours post laser. No major iris haemorrhage occurred
in our study, which is a known complication of YAG laser
when used alone in dark eyes. Another study from Pakistan
has reported hyphaema in 48% and post laser pressure rise
in 14% of cases using YAG laser for iridotomy alone.16
Other studies in USA have reported hyphaema in 45%
cases.11,17 The risk of iris haemorrhage decreases in
combined Argon-Yag laser iridotomy due to less amount of
total YAG energy requirement.18 Another study from USA
reported that argon laser pretreatment decreased intra-
operative haemorrhage from 67% to 12%.8
Post laser anterior uveitis with anterior chamber
reaction was noted in 32 (80%) eyes. In most of the cases it
settled within 48-72 hours with topical steroids four times a
day for 5 to 7 days. In one eye the anterior uveitis lasted for
about 4 weeks. 
Corneal endothelial damage was noted in 2 patients
(5%) in our study. Both patients had suffered acute angle
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Table-3: Complications of laser iridotomy using Argon laser followed
by YAG laser at a tertiary care hospital in Pakistan (n=40 eyes).
Per-operative Complications % Affected
Transient hyphaema 14 (35%)
Pain in the eye 2 (5%)
Corneal damage 2 (5%)
Pigment release 40 (100%)
2 hours post laser
Transient rise of IOP 18 (45%)
Transient iritis 32 (80%)
Transient hyphaema 2 (5%)
One day post laser
Transient iritis 22 (55%)
Transient rise of IOP* 13 (32.5%)
Transient hyphaema 4 (10%)
1 week post laser
Transient iritis 1(2.5%)
Transient rise of IOP 1(2.5%)
Corneal damage 1(2.5%)
Posterior Synechiae Formation 1(2.5%)
Lens opacity 1 (2.5%)
Closure of iridotomy Nil (0%)
hyphaema Nil (0%)
*IOP: Intra Ocular pressure.
closure attack with a very shallow anterior chamber and
irido corneal contact. The lesions were small and self
limiting and resolved with time. Proper focusing may
minimize this problem. Studies have reported 4 to 35 % of
eyes developing focal endothelial changes post YAG laser
iridotomy.12,14,19,20 High levels of energy required in dark
iridies with Yag laser alone may also adversely affect the
endothelial cell count.19,21
One patient developed a post laser anterior
subcapsular lens opacity, under the iridotomy site, which
was non progressive. 
Formation of posterior synechae occurred in one
patient only on the third post laser day. It was treated with a
short acting mydriatic. Formation of posterior synechie is
more common after Argon laser iridotomy alone. They can
usually be prevented by dilating the pupil and treating the
inflammation appropriately.22
There was a transient elevation of IOP in (45%) of
our cases which was controlled with topical beta blockers.
The average rise of  IOP was 10 mmHg (range 4-20mmHg).
This pressure spike resolved in almost all the patients within
2 weeks without any sequlea.
Conclusion
The combined Argon-Yag laser iridotomy is an
effective technique to use in our population, because of the
thicker and more heavily pigmented irides. It reduces the
risk of iris haemorrhage and high patency is achieved after
the primary treatment.
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